PARKINSON’S DISEASE: TREATMENT OF EARLY STAGE DISEASE
Abstract
The paper reviews the literature data related to the treatment of early Parkinson’s disease and discusses the advantages and disadvantages of monotherapy, principles of drug selection, features of treatment of patients of different ages, and the use of new form of pramipexole with sustained release.
About the Authors
A. V. Rosinskaya
Primorsky Regional Clinical Hospital No. 1
Russian Federation
Russian Federation
V. K. Datieva
Russian Medical Academy of Post-Graduate Education
Russian Federation
Russian Federation
References
1. Голубев В.Л., Левин Я.И., Вейн А.М. Болезнь Паркинсона и синдром паркинсонизма. М.: МЕДпресс, 1999. 416 с
2. Левин О.С., Федорова Н.В., Смоленцева И.Г. Агонисты дофаминовых рецепторов в лечении болезни Паркинсона // Русский медицинский журнал. 2000. № 15-16. С. 643-646.
3. Левин О.С., Федорова Н.В. Болезнь Паркинсона. М.: МЕДпресс-информ, 2011. 351 с.
4. Протокол ведения больных. Болезнь Паркинсона // Пробл. стандартизации в здравоохр. 2005. № 3. С. 74-166.
5. Chwieduk C.M., Curran M.P. Pramipexole extended release in Parkinson’s disease // CNS Drugs. 2010. Vol. 24. P. 327-336.
6. Grosset K.A., Bone I., Grosset D.G. Suboptimal Medication Adherence in Parkinson’s Disease // Mov. Disord. 2005. Vol. 20, No. 11. P. 1502-1507.
7. Hauser R., Salin L., Koester J. Double-blind evaluation of pramipexole extended-release (ER) in early Parkinson’s disease // Neurology. 2009. Vol. 72, No. 11, Suppl. 3. P. A412-A413.
8. Kvernmo T., Härtter S., Bürger E. A review of the receptor-binding and pharmacokinetic properties of dopamine agonists // Clin. Ther. 2006. Vol. 28. P. 1065-1078.
9. Mizuno Y., Yamamoto M., Kuno S. et al. Efficacy of pramipexole extended release (ER) and switching from pramipexole immediate release (IR) to ER in Japanese advanced Parkinson’s disease (PD) patients // Proceedings of the 18th WFN World Congress on Parkinson’s Disease and Related Disorders; Miami Beach, FL, USA. 2009. Poster 2.192.
10. Möller J.C., Oertel W.H. Pramipexole in the treatment of Parkinson’s disease: new developments // Expert Rev. Neurother. 2005. Vol. 5. P. 581-586.
11. Poewe W., Rascol O., Barone P. et al. Pramipexole extended-release in early Parkinson’s disease // Neurology. 2011. Vol. 77. P. 759-766.
Review
For citations:
Rosinskaya A.V., Datieva V.K. PARKINSON’S DISEASE: TREATMENT OF EARLY STAGE DISEASE. Pacific Medical Journal. 2013;(4):55-59. (In Russ.)
Views:
221
Email this article 